Next Article in Journal
High Update Rate Attitude Measurement Method of Star Sensors Based on Star Point Correction of Rolling Shutter Exposure
Previous Article in Journal
Robust Measurement-Driven Cardinality Balance Multi-Target Multi-Bernoulli Filter
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Development of a New Submaximal Walk Test to Predict Maximal Oxygen Consumption in Healthy Adults

1
Exercise Medicine Center for Diabetes and Cancer Patients, ICONS, Yonsei University, Seoul 03722, Korea
2
Department of Sport Industry Studies, Yonsei University, Seoul 03722, Korea
3
Department of Exercise Science, David B. Falk College of Sport and Human Dynamics, Syracuse University, Syracuse, NY 13210, USA
4
Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA
5
Department of Physical Education, Yonsei University, Seoul 03722, Korea
6
Cancer Prevention Center, Yonsei Cancer Center, Yonsei University College of Medicine, Yonsei University, Seoul 03722, Korea
*
Author to whom correspondence should be addressed.
Sensors 2021, 21(17), 5726; https://doi.org/10.3390/s21175726
Submission received: 30 June 2021 / Revised: 9 August 2021 / Accepted: 19 August 2021 / Published: 25 August 2021
(This article belongs to the Section Biomedical Sensors)

Abstract

:
The aim of the study was to develop a simple submaximal walk test protocol and equation using heart rate (HR) response variables to predict maximal oxygen consumption (VO2max). A total of 60 healthy adults were recruited to test the validity of 3 min walk tests (3MWT). VO2max and HR responses during the 3MWTs were measured. Multiple regression analysis was used to develop prediction equations. As a result, HR response variables including resting HR and HR during walking and recovery at two different cadences were significantly correlated with VO2max. The equations developed using multiple regression analyses were able to predict VO2max values (r = 0.75–0.84; r2 = 0.57–0.70; standard error of estimate (SEE) = 4.80–5.25 mL/kg/min). The equation that predicted VO2max the best was at the cadence of 120 steps per minute, which included sex; age; height; weight; body mass index; resting HR; HR at 1 min, 2 min and 3 min; HR recovery at 1 min and 2 min; and other HR variables calculated based on these measured HR variables (r = 0.84; r2 = 0.70; SEE = 4.80 mL/kg/min). In conclusion, the 3MWT developed in this study is a safe and practical submaximal exercise protocol for healthy adults to predict VO2max accurately, even compared to the well-established submaximal exercise protocols, and merits further investigation.

1. Introduction

Cardiorespiratory fitness (CRF) is an important indicator of health, various chronic diseases and mortality, which has established itself alongside conventional health indicators such as BMI, blood pressure, drinking and smoking [1,2,3,4]. However, despite its importance and practical implications, the CRF is rarely used in healthcare practice [5,6] due to the fact that the gold standard measure of CRF, maximal oxygen consumption (VO2max), requires expensive equipment, trained specialists and maximal effort by participants until volitional fatigue [7]. Due to health risks, cost and inconvenience of the VO2max test, submaximal exercise protocols, which do not use a metabolic cart, have been developed to estimate one’s CRF [8,9,10,11,12,13]. Indirect submaximal exercise protocols generally require less expensive specialized equipment, are easier and safer to perform and are utilized more frequently in clinical practice and epidemiological studies. The main variables used in the equations to predict VO2max include HR (HR) variables. One of the HR variables commonly utilized is the resting heart rate (RHR), an important vital sign and indicator of CRF. Elevated RHR shows associations with various health conditions including cardiovascular and non-cardiovascular mortality [14,15,16]. HR during exercise is also a common indicator that reflects the intensity of exercise. Previous submaximal protocols with set or standardized workloads have, therefore, used HR to extrapolate or predict VO2max [12,13,17]. Finally, HR recovery after submaximal exercise has also been used to predict VO2max. A delayed HR recovery is a recognized risk factor for cardiovascular events and mortality [18,19].
Recent research studies on VO2max prediction have incorporated the use of technology and have gone as far as estimating VO2max without the need to perform predefined protocols. Cao et al. used objectively measured physical activity levels to predict VO2max, and Altini et al. used wearable sensors to identify context-specific intensity during ‘free-living’ and used HR to predict VO2max [20,21]. Although such approaches are novel and offer easy means to predict VO2max, these methods are still being tested and require specialized equipment, making it difficult for the general population to use. When these prediction methods are validated and become more readily available, the knowledge and testing of VO2max values may become commonplace. However, despite its potential health implications, the current understanding of VO2max in the general population is lacking [6].
This discrepancy may partially be caused by the limitations of the previously developed submaximal exercise protocols such as being complicated or inconvenient to perform, being too strenuous or requiring access to specialized equipment or trained specialists. Additionally, the majority of submaximal protocols used today were developed several decades ago and do not utilize the technology which has become readily available today. Hence, there is still a need to develop a submaximal exercise protocol that is safe, easy and convenient to perform by using tools that are readily available to the general public. Therefore, the purpose of this study was to test the feasibility of simple 3 min walk test (3MWT) protocols in healthy adults and to test if HR responses during the 3MWT protocols can be used to estimate VO2max in healthy adults.

2. Method

2.1. Participants

A total of 60 adults (40 males and 20 females) were included in this study. Participants between the ages of 18 and 40 years were recruited by using convenience sampling, and all participants were screened for contraindications of exercise using a physical activity readiness questionnaire (PAR-Q) [22] before testing. The experimental protocol was approved by the Institutional Review Board of Yonsei University, and all methods were carried out in accordance with the Declaration of Helsinki. All participants provided signed informed consent forms.

2.2. Procedure

Participants were instructed to abstain from activities that may influence testing such as moderate-high intensity exercise or alcohol consumption 48 h prior to testing and to abstain from ingestion of caffeine, alcohol, energy drinks and heavy meals 3 h prior to testing [23]. On the day of testing, participants were given a detailed explanation of the testing procedures, and the participants were familiarized with all testing protocol and equipment in order to minimize external physical or psychological influence. They were then asked to sign an informed consent form and given a brief questionnaire, including the Korean Global Physical Activity Questionnaire [24]. Participants were provided with light exercise apparel (t-shirt and shorts) for testing. The testing environment was controlled to 24–26 °C before participants arrived. Participants first underwent anthropometric measurements, followed by the 3MWTs and ended with a maximal graded exercise test with direct VO2max measurements. The female participants were scheduled for testing on a day that did not coincide with menstruation in order to minimize discomfort and influence on HR [25].

2.3. Measurements

Height, weight and body composition were measured by using a stadiometer and Inbody 720 (Biospace Co., Seoul, Korea). The waist circumference and leg length were measured with a standard tape measure, standing with heels 10 cm apart and feet pointing forward. Waist circumference was measured at the naval and leg length was measured from the greater trochanter to the floor on both legs. All measurements were conducted two times, measured to the nearest 0.1 cm and repeated a third time if the previous measurements had a difference greater than 0.5 cm.

2.4. The 3 Min Walk Test Protocol

In order to develop a new submaximal walk test, a pretest was conducted to determine the most appropriate cadence. Appropriateness was determined by whether it could be performed safely, whether the diverse range of participants was physically able to perform the cadence and whether the cadence elicited a sufficient exercise response (50–80% predicted HR max). The cadences of 120 steps per minute (spm) and 130 spm were determined to be the most appropriate potential cadences for the walk test out of the 6 cadences tested (100 spm, 110 spm, 120 spm, 130 spm, 140 spm and 150 spm). A walking duration of three minutes was chosen as the duration of exercise to minimize the testing time while ensuring that a steady HR (plateau) was achieved [26]. The final 3MWT protocols involved continuous brisk walking for three minutes followed by two minutes of rest in a standing position. This was performed twice, once at a cadence of 120 spm (3MWT120) and once at a cadence of 130 spm (3MWT130).
The participants were asked to put on a commercially available Polar H7 (Polar Electro, Finland) chest strap. Continuous HR data from the H7 was saved on a smart phone in real time and was analyzed on a computer. Once the H7 sensor was strapped on and working properly, the participants sat on a chair at the start line and were given detailed instructions regarding the 3MWT. The instructions and verbal encouragements that were given prior to and during the protocol were standardized and rehearsed before testing.
Once the participants reach a resting state, defined as a HR change of ≤3 bpm for 1 min, the participants began the 3MWT. Participants walked back and forth along a 30 m course marked out on the ground, covering as much ground as possible at a cadence of 120 spm for three minutes (3MWT120), followed by two minutes of rest. The steps were walked in beat to the tempo from a free metronome app on a smart phone (Tempo version 3). During rest, the metronome was turned off, and the participants were instructed to concentrate on recovery and to minimize activity. The rate of perceived exertion (RPE) was measured at the end of rest, using a 15-point Borg RPE scale, and the total distance covered was recorded. This protocol was repeated at a faster cadence of 130 spm (3MWT130) once the participants achieved a resting state. Participants were instructed to walk in beat to the metronome, and participants that missed ≥6 steps (95% of protocol) for either 3MWT protocols were excluded from the analysis.

2.5. HR Variables

Continuous HR data was collected and stored in real time using the Heart Rate Variability Logger (by Marco Altini) App. For analysis, HR was then calculated from the RR intervals provided on the App. HR variables included RHR; HR during exercise at 1 min (HR1m), 2 min (HR2m) and 3 min (HR3m); and HR recovery at 30 s (HRR30s), 1 min (HRR1m) and 2 min (HRR2m). Furthermore, additional HR variables were calculated by using measured HR variables in an effort to increase the validity of the VO2max prediction equations. Advancements in technology have now made it possible to measure continuous HR with ease (before, during and after exercise) and to have the data analyzed automatically. Calculated variables in this study are categorized into four categories: (1) dynamics of HR response to walking or how quickly the HR increases once walking begins, i.e., RHR to HR at 1, 2 and 3 min of exercise (HR1m–RHR, HR2m–RHR, HR3m–RHR, HR2m-HR1m, HR3m–HR2m, respectively); (2) recovery or the decrease in heart rate after cessation of walking, i.e., HR from exercise at 3 min to 30 s, 1 min and 2 min of rest (HRR30s–HR3m, HRR1m–HR3m, HRR2m–HR3m, HRR30s–HRR1m, HRR30s–HRR2m, HRR1m–HRR2m, respectively); (3) total change in HR or HR response (square root ((increase in HR during exercise)2 + (decrease in HR after exercise)2))(RHR to HR3m to HRR30s, RHR to HR3m to HRR1m, RHR to HR3m to HRR2m); (4) ability to recover after exercise or the difference in HR between RHR and HR recovery at 30 s, 1 min and 2 min (HRR30s–RHR, HRR1m–RHR, HRR2m–RHR, respectively).

2.6. Maximal Graded Exercise Protocol

The Bruce protocol was used to directly measure VO2max and was conducted in accordance to the standard procedure [27]. The Q-Stress TM65 treadmill (Cardiac Science Co., WA, USA) was used for testing, and the MMS-2400 metabolic cart (Cardiac Science Co., USA), which is compatible with the Polar H7, was used to collect data. All instructions regarding the protocol and safety, as well as verbal encouragements, were standardized and rehearsed before testing. The lead investigator monitored the data during testing while an additional investigator monitored the participants during testing to ensure safety. The protocol continued until volitional fatigue, at which point the treadmill gradient was immediately lowered to 0° and the speed reduced to a slow walking pace for five minutes. In order for the results to be considered a valid VO2max, two of the following three criteria needed to be met: respiratory exchange ratio of >1.1, maximal HR of >85% of age predicted maximal HR and an RPE ≥18 on the Borg scale.

2.7. Statistical Analysis

All analyses were performed using SPSS 22 (IBM, NY, USA) with a level of significance set at p < 0.05. Differences between means in the descriptive analysis were compared by using analysis of variance (ANOVA). The Pearson correlation analysis was conducted to identify any possible independent variables that were then included in the final prediction equation. After possible independent variables were identified, stepwise regression analysis was used to determine which variables best predicted VO2max. Four sets of equations were developed using the following: (1) no HR variables, (2) only HR variables that were directly measured, (3) only HR variables that were calculated using two or more measured HR variables and (4) a combination of both measured and calculated HR variables.

3. Results

3.1. Participant Characteristics

A total of 60 participants were included for analysis, of which 40 were males and 20 were females. Participant characteristics are presented in Table 1. The mean age of both the male and female participants was 26 years of age. The majority of participants had ‘good’ or ‘very good’ VO2max scores when compared to Korean sex and age-appropriate reference values.

3.2. HR Characteristics

The mean HR responses to the 3MWT120 and the 3MWT130 can be observed in Figure 1. The mean HR was 69 bpm at rest, reached 130 bpm and 139 bpm during exercise and dropped to 86 bpm and 93 bpm after two minutes of recovery for the 3MWT120 and the 3MWT130, respectively.
HR variables during and after exercise were significantly higher in the 3MWT130 compared to the 3MWT120. HR responses according to sex for the 3MWT120 and the 3MWT130 are presented in Table 2. There were significant differences in HR responses to the 3MWT between males and females, with females showing higher HRs during the 3MWT. There were also significant differences between HR responses to the 3MWT120 and the 3MWT130, with HR being significantly higher during walking and recovery for 3MWT130 in both men and women. The total distance covered and RPE scores were also significantly higher for the 3MWT130.
Correlations between anthropometric variables and HR during the 3MWT are presented in Table 3. The VO2max values were significantly correlated with sex, height, weight, leg length and total distance walked. The total distance walked and RPE scores during the 3MWT were significantly associated with all HR variables during the 3MWT at two different cadences and recovery. Although not presented in the table, total distance walked was also significantly correlated with sex, height, weight and leg length.
Correlations of measured and calculated HR variables with VO2max are presented in Table 4. For both the 3MWT120 and the 3MWT130, most measured HR variables showed weak but significant correlations with VO2max. On the other hand, most calculated HR variables showed weaker correlations with VO2max and did not show significant correlations with VO2max.
Table 5 shows the equations used to predict measured VO2max values using no HR variables, only measured HR variables, only calculated HR variables or a combination of both measured and calculated HR related variables. Equations that used no HR variables showed the lowest r-values (3MWT: r = 0.75) and r2-values (3MWT: r2 = 0.57). Equations that used a combination of both measured and calculated HR related variables resulted in the highest r-values (3MWT120: r = 0.84; 3MWT130: r = 0.81) and r2-values (3MWT120: r2 = 0.70; 3MWT130: r2 = 0.65), while the 3MWT120 also had the smallest SEE (3MWT120: SEE = 4.80 mL/kg/min).

4. Discussion

The data of 60 participants was used to test the feasibility of a new submaximal walk test developed in this study to predict VO2max. Correlation analysis showed VO2max to be significantly associated with anthropometric variables and measured HR related variables but less so with the calculated HR related variables. Multiple regression analyses were conducted to develop four equations for both the 3MWT120 and the 3MWT130 that used no HR variables, only measured HR variables, only calculated HR variables and a combination of both measured and calculated HR related variables. The set of equations that used a combination of both measured and calculated HR related variables best predicted measured VO2max values. All equations only included variables that can be measured using basic tools and a HR monitor. Although total distance covered during the 3MWT and RPE showed a significant correlation with VO2max, these variables did not increase the accuracy of the predictions and were excluded from the final equation, thereby making the 3MWT more practical and convenient to conduct.
The diverse range of calculated HR related variables was investigated to identify new potential HR variables that increased the accuracy of the prediction equation. Calculated HR related variables showed weak correlations with VO2max values that failed to reach statistical significance. Although no new HR related variables were identified, equations that used a combination of both measured and calculated HR related variables showed improved accuracy in predicting measured VO2max values. For the final equation, the calculated HR variables were squared to exaggerate the differences. It was surprising to find that the final prediction equation using a combination of measured and calculated HR variables for the 3MWT120 was better at estimating VO2max than the equation for the 3MWT130, since the 3MWT130 elicited a higher exercise response. This suggests that the 3MWT120 may be the more feasible protocol of the two that were tested. However, a larger, more representative sample of the general population is needed before the most appropriate 3MWT can be determined.
A limitation of this study is the relatively small sample size of young healthy adults, 56.7% of which were classified as fit according to the Korean sex and age-appropriate reference values. Although this sample may not be representative of the general population, a protocol that can be used to accurately predict VO2max in the general population would require the protocol to elicit a sufficient exercise response in a young fit population while being easy enough for the aged unfit population to perform. In this regard, the sample of this pilot test is the most appropriate sample for investigating the feasibility of this protocol before testing on an older, less healthy sample. A study that used a similar sample size (n = 53 and n = 27) of fit college-aged participants for predicting VO2max by using the one-mile run and 1.5 mile run found r-values of 0.87 and 0.90, respectively [13]. Another study that used a small homogenous sample (38 females) to compare the ability of commonly used submaximal exercise protocols to predict VO2max found r-values of r = 0.73, r = 0.79, r = 0.55 and r = 0.66 for the 1.5 mile run, the one-mile walk test, the Queen’s step test and the Astrand–Rhyming nomogram using the extrapolation method, respectively [28]. Another study that used a small homogenous sample (21 young well-trained men) found the American College of Sports Medicine’s submaximal treadmill running test and a modified version of the same test to predict VO2max and found r-values of r = 0.65 and r = 0.64, respectively [29]. Although the findings of the current study cannot be directly compared to the findings of previous studies that have investigated the ability of submaximal exercise protocols to predict VO2max on small homogenous samples, they do provide a reference for the findings of this study. The results of the 3MWT are encouraging and warrant further examination, especially since the r-values fared well compared to the results of studies that investigated the most commonly used submaximal protocols. Compared to ‘gold-standard’ submaximal protocols, the 3MWT also requires less specialized equipment, less strenuous activity and minimum supervision while being more convenient to perform. This study used a gold standard HR monitor to measure continuous HR because, although studies have validated the use of smart phones to monitor HR, further investigations are needed to understand the influence of different smartphone features before a consensus on its use in healthcare can be established [30]. However, if the use of smartphones as HR monitors were to become common practice in healthcare, the 3MWT would provide a convenient method for estimating VO2max for anyone owning a smartphone.
In conclusion, this study was able to develop a safe, convenient and more practical submaximal exercise protocol that is able to predict VO2max accurately (r = 0.84, r2 = 0.70, SEE = 4.80 mL/kg/min). This study also identified new HR related variables that can be used to increase the accuracy of VO2max prediction, while using basic tools that are easily accessible. Although the small homogenous sample makes it difficult to generalize, the initial results are promising and warrant further study in a larger and more heterogeneous population.

Author Contributions

Conceptualization, H.I.Y. and J.Y.J.; formal analysis, H.I.Y.; funding acquisition, J.Y.J.; investigation, H.I.Y., W.C., D.H.L., S.-H.S. and J.Y.J.; supervision, J.Y.J.; writing—original draft, H.I.Y.; writing—review and editing, W.C., D.H.L., S.-H.S. and J.Y.J. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by Samsung Electronics through Yonsei University (project number 2015-110-1098), the National Research Foundation of Korea (NRF-2015S1A5B8036349) and Yonsei Signature Research Cluster Program of 2021-22-0009.

Institutional Review Board Statement

This study was conduct according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Review Board of Yonsei University (IRB No. 7001988-2017-SB-115-02).

Informed Consent Statement

Informed consent was obtained from all individual participants included in the study.

Data Availability Statement

The datasets generated and/or analyzed during the current study are available from the corresponding author upon reasonable request.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Laukkanen, J.A.; Kurl, S.; Salonen, R.; Rauramaa, R.; Salonen, J.T. The predictive value of cardiorespiratory fitness for cardiovascular events in men with various risk profiles: A prospective population-based cohort study. Eur. Heart J. 2004, 25, 1428–1437. [Google Scholar] [CrossRef] [PubMed]
  2. Lee, D.-C.; Artero, E.G.; Sui, X.; Blair, S.N. Review: Mortality trends in the general population: The importance of cardiorespiratory fitness. J. Psychopharmacol. 2010, 24, 27–35. [Google Scholar] [CrossRef]
  3. Kodama, S.; Saito, K.; Tanaka, S.; Maki, M.; Yachi, Y.; Asumi, M.; Sugawara, A.; Totsuka, K.; Shimano, H.; Ohashi, Y.; et al. Cardiorespiratory Fitness as a Quantitative Predictor of All-Cause Mortality and Cardiovascular Events in Healthy Men and Women a Meta-Analysis. JAMA J. Am. Med Assoc. 2009, 301, 2024–2035. [Google Scholar] [CrossRef] [Green Version]
  4. Carnethon, M.R.; Gidding, S.S.; Nehgme, R.; Sidney, S.; Jacobs, D.R., Jr.; Liu, K. Cardiorespiratory Fitness in Young Adulthood and the Development of Cardiovascular Disease Risk Factors. JAMA 2003, 290, 3092–3100. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Forman, D.E.; Myers, J.; Lavie, C.J.; Guazzi, M.; Celli, B.; Arena, R. Cardiopulmonary Exercise Testing: Relevant but Underused. Postgrad. Med. 2010, 122, 68–86. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Kaminsky, L.A.; Arena, R.; Beckie, T.M.; Brubaker, P.H.; Church, T.S.; Forman, D.E.; Franklin, B.A.; Gulati, M.; Lavie, C.J.; Myers, J.; et al. The Importance of Cardiorespiratory Fitness in the United States: The Need for a National Registry: A Policy Statement from the American Heart Association. Circulation 2013, 127, 652–662. [Google Scholar] [CrossRef] [Green Version]
  7. American Thoracic Society, and American College of Chest Physicians. Ats/Accp Statement on Cardiopulmonary Exercise Testing. Am. J. Respir. Crit. Care Med. 2003, 167, 211–277. [Google Scholar] [CrossRef] [PubMed]
  8. Astrand, I. Aerobic work capacity in men and women with special reference to age. Acta Physiol. Scand. Suppl. 1960, 49, 1. [Google Scholar]
  9. Ebbeling, C.B.; Ward, A.; Puleo, E.M.; Widrick, J.; Rippe, J.M. Development of a single-stage submaximal treadmill walking test. Med. Sci. Sports Exerc. 1991, 23, 966–973. [Google Scholar] [CrossRef]
  10. Golding, L.A.; Myers, C.R.; Sinning, W.E. Y’s Way to Phisycal Fitness: The Complete Guide to Fitness Testing and Instruction; Human Kinetics: Champaign, IL, USA, 1989. [Google Scholar]
  11. Léger, L.; Lambert, J.; Hercier, D. Predicted Vo2max and Maximal Speed for a Multistage 20-M Shuttle Run in 7000 Quebec Children Aged 6–17. Med. Sci. Sports Exerc. 1983, 15, 142. [Google Scholar]
  12. Kline, G.M.; Porcari, J.P.; Hintermeister, R.; Freedson, P.S.; Ward, A.; McCarron, R.F.; Ross, J.; Rippe, J.M. Estimation of VO2max from a one-mile track walk, gender, age, and body weight. Med. Sci. Sports Exerc. 1987, 19, 253–259. [Google Scholar] [CrossRef]
  13. George, J.D.; Vehrs, P.R.; Allsen, P.E.; Fellingham, G.W.; Fisher, A.G. VO2max estimation from a submaximal 1-mile track jog for fit college-age individuals. Med. Sci. Sports Exerc. 1993, 25, 401–406. [Google Scholar] [CrossRef] [PubMed]
  14. Fox, K.; Borer, J.S.; Camm, A.J.; Danchin, N.; Ferrari, R.; Sendon, J.L.L.; Steg, P.G.; Tardif, J.-C.; Tavazzi, L.; Tendera, M. Resting Heart Rate in Cardiovascular Disease. J. Am. Coll. Cardiol. 2007, 50, 823–830. [Google Scholar] [CrossRef] [Green Version]
  15. Kannel, W.B.; Kannel, C.; Paffenbarger, R.S., Jr.; Cupples, L.A. Heart Rate and Cardiovascular Mortality: The Framingham Study. Am. Heart J. 1987, 113, 1489–1494. [Google Scholar] [CrossRef]
  16. Palatini, P.; Julius, S. Heart rate and the cardiovascular risk. J. Hypertens. 1997, 15, 3–17. [Google Scholar] [CrossRef] [PubMed]
  17. Astrand, P.O.; Ryhming, I. A Nomogram for Calculation of Aerobic Capacity (Physical Fitness) from Pulse Rate During Sub-Maximal Work. J. Appl. Physiol. 1954, 7, 218–221. [Google Scholar] [CrossRef]
  18. Cole, C.R.; Blackstone, E.H.; Pashkow, F.J.; Snader, C.E.; Lauer, M.S. Heart-Rate Recovery Immediately after Exercise as a Predictor of Mortality. N. Engl. J. Med. 1999, 341, 1351–1357. [Google Scholar] [CrossRef] [PubMed]
  19. Cole, C.R.; Foody, J.M.; Blackstone, E.H.; Lauer, M.S. Heart rate recovery after submaximal exercise testing as a predictor of mortality in a cardiovascularly healthy cohort. Ann. Intern. Med. 2000, 132, 552–555. [Google Scholar] [CrossRef]
  20. Cao, Z.-B.; Miyatake, N.; Higuchi, M.; Miyachi, M.; Ishikawa-Takata, K.; Tabata, I. Predicting V˙O2max with an Objectively Measured Physical Activity in Japanese Women. Med. Sci. Sports Exerc. 2010, 42, 179–186. [Google Scholar] [CrossRef] [PubMed]
  21. Altini, M.; Casale, P.; Penders, J.; Amft, O. Cardiorespiratory fitness estimation in free-living using wearable sensors. Artif. Intell. Med. 2016, 68, 37–46. [Google Scholar] [CrossRef]
  22. Thomas, S.; Reading, J.; Shephard, R.J. Revision of the Physical Activity Readiness Questionnaire (PAR-Q). Can. J. Sport Sci. 1992, 17, 338–345. [Google Scholar] [PubMed]
  23. American College of Sports Medicine. Acsm’s Guidelines for Exercise Testing and Prescription; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2013. [Google Scholar]
  24. Lee, J.; Lee, C.; Min, J.; Kang, D.-W.; Kim, J.-Y.; Yang, H.I.; Park, J.; Lee, M.-K.; Park, I.; Jae, S.Y.; et al. Development of the Korean Global Physical Activity Questionnaire: Reliability and validity study. Glob. Health Promot. 2019, 27, 44–55. [Google Scholar] [CrossRef] [PubMed]
  25. Moran, V.H.; Leathard, H.L.; Coley, J. Cardiovascular functioning during the menstrual cycle. Clin. Physiol. 2000, 20, 496–504. [Google Scholar] [CrossRef]
  26. Sharon, A.P.; Smith, D.L. Exercise Physiology for Health Fitness and Performance; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2013. [Google Scholar]
  27. Bruce, R.A.; Blackmon, J.R.; Jones, J.W.; Strait, G. Exercising Testing in Adult Normal Subjects and Cardiac Patients. Pediatrics 1963, 32, 742–756. [Google Scholar] [CrossRef] [PubMed]
  28. Zwiren, L.D.; Freedson, P.S.; Ward, A.; Wilke, S.; Rippe, J.M. Estimation of VO2max: A Comparative Analysis of Five Exercise Tests. Res. Q. Exerc. Sport 1991, 62, 73–78. [Google Scholar] [CrossRef]
  29. Clare, E.M. Evaluation of the American College of Sports Medicine Submaximal Treadmill Running Test for Predicting Vo2max. J. Strength Cond. Res. 2012, 26, 548–554. [Google Scholar]
  30. Parpinel, M.; Scherling, L.; Lazzer, S.; Della Mea, V. Reliability of heart rate mobile apps in young healthy adults: Exploratory study and research directions. J. Innov. Health Inform. 2017, 24, 224–227. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Figure 1. Heart rate response during the 3MWT at a cadence of 120 spm and 130 spm; * significant difference of p < 0.05. Abbreviation: 3MWT120, 3 min walk test at a cadence of 120 spm; 3MWT130, 3 min walk test at a cadence of 130 spm; spm, steps per minute; RHR, resting heart rate; HR1, heart rate at 1 min of exercise; HR2, heart rate at 2 min of exercise; HR3, heart rate at 3 min of exercise; HRR1, heart rate recovery at 1 min; HRR2, heart rate recovery at 2 min.
Figure 1. Heart rate response during the 3MWT at a cadence of 120 spm and 130 spm; * significant difference of p < 0.05. Abbreviation: 3MWT120, 3 min walk test at a cadence of 120 spm; 3MWT130, 3 min walk test at a cadence of 130 spm; spm, steps per minute; RHR, resting heart rate; HR1, heart rate at 1 min of exercise; HR2, heart rate at 2 min of exercise; HR3, heart rate at 3 min of exercise; HRR1, heart rate recovery at 1 min; HRR2, heart rate recovery at 2 min.
Sensors 21 05726 g001
Table 1. Participants’ physical characteristics.
Table 1. Participants’ physical characteristics.
VariablesTotal
(n = 60)
Male
(n = 40)
Female
(n = 20)
Age (years)26.35 ± 4.5226.50 ± 4.2526.05 ± 5.13
Height (cm)173.50 ± 8.29177.79 ± 5.58164.92 ± 5.76 *
Weight (kg)71.67 ± 12.2077.99 ± 9.2059.03 ± 6.03 *
Body Mass Index (kg/m2)23.68 ± 2.8426.69 ± 2.7521.68 ± 1.78 *
Waist Circumference (cm)80.64 ± 7.9293.45 ± 7.4585.02 ± 5.56 *
Leg Length (cm)86.61 ± 4.6488.72 ± 3.5682.38 ± 3.54 *
Body Fat Percent (%)20.86 ± 6.1017.95 ± 5.3026.68 ± 4.02 *
Body Muscle Percent (%)44.59 ± 6.3546.86 ± 3.1940.05 ± 2.31 *
Maximal Oxygen Consumption (ml/kg/min)44.98 ± 7.2448.33 ± 5.9638.29 ± 4.37 *
Fit individuals a (%)56.7%60%50%
Data is presented as mean ± standard deviation; * significant difference of p < 0.05, between males and females; a maximal oxygen consumption results were compared to the Korean age and sex appropriate reference values for males and females, and those with ‘good’ or ‘very good’ were classified as ‘fit individual’s.
Table 2. Characteristics of the measured exercise related variables.
Table 2. Characteristics of the measured exercise related variables.
VariablesMale
(n = 40)
Female
(n = 20)
Resting Heart Rate68.18 ± 9.7470.25 ± 8.00
3MWT at a cadence of 120 spm
HR1m (bpm)119.15 ± 12.98128.90 ± 11.24 *
HR2m (bpm)125.15 ± 15.61139.45 ± 14.65 *
HR3m (bpm)126.78 ± 15.89139.50 ± 17.32 *
HRR30s (bpm)109.08 ± 15.99120.35 ± 22.96 *
HRR1m (bpm)94.73 ± 14.53100.85 ± 19.03
HRR2m (bpm)85.38 ± 14.0387.05 ± 15.17
Distance walked (m)346.29 ± 25.09331.40 ± 20.26 *
RPE10.90 ± 2.7111.75 ± 1.59
3MWT at a cadence of 130 spm
HR1m (bpm)124.50 ± 14.28 #133.30 ± 14.25 *#
HR2m (bpm)132.48 ± 17.60 #143.70 ± 16.82 *#
HR3m (bpm)134.78 ± 19.06 #148.05 ± 16.58 *#
HRR30s (bpm)119.65 ± 17.53 #130.20 ± 20.52 *#
HRR1m (bpm)103.78 ± 15.88 #108.60 ± 20.49 #
HRR2m (bpm)91.13 ± 14.12 #95.70 ± 17.00 #
Distance walked (m)368.85 ± 23.79 #350.38 ± 19.06 *#
RPE12.08 ± 1.99 #12.30 ± 1.75 #
Data is presented as mean ± standard deviation; * significant difference of p < 0.05, between males and females; # significant difference of p < 0.05, between 3MWT at a cadence of 120 spm and 130 spm. Abbreviations: VO2max, maximal oxygen consumption; 3MWT, 3 min walk test; spm, steps per minute; HR1m, heart rate at 1 min; HR2m, heart rate at 2 min; HR3m, heart rate at 3 min; HRR30s, heart rate recovery at 30 s; HRR1m, heart rate recovery at 1 min; HRR2m, heart rate recovery at 2 min; RPE, rate of perceived exertion.
Table 3. Correlation of anthropometric measurements and exercise related variables.
Table 3. Correlation of anthropometric measurements and exercise related variables.
SexAgeHeightWeightBMIWCLLDistRPE
VO2max (mL/kg/min)−0.66 **−0.200.39 **0.39 **0.250.140.47 **0.28 *−0.20
RHR0.11−0.150.03−0.01−0.040.01−0.02−0.080.26 *
3MWT at a cadence of 120 spm
HR1m (bpm)0.35 **−0.22−0.16−0.26 *−0.25−0.17−0.160.31 *0.39 **
HR2m (bpm)0.41 **−0.11−0.20−0.31 *−0.28 *−0.18−0.220.32 *0.37 **
HR3m (bpm)0.30 **−0.12−0.14−0.25−0.25−0.15−0.180.39 **0.38 **
HRR30s (bpm)0.28 *−0.10−0.11−0.25−0.26−0.21−0.180.38 **0.41 **
HRR1m (bpm)0.21−0.11−0.05−0.20−0.24−0.15−0.110.31 *0.38 **
HRR2m (bpm)0.06−0.11−0.17−0.17−0.27 *−0.17−0.030.26 *0.31 *
3MWT at a cadence of 130 spm
HR1m (bpm)0.28 *−0.31 *−0.24−0.24−0.27 *−0.17−0.100.39 **0.36 **
HR2m (bpm)0.27 *−0.13−0.18−0.17−0.18−0.07−0.100.43 **0.40 **
HR3m (bpm)0.33 *−0.17−0.26 *−0.26 *−0.28 *−0.13−0.160.41 **0.50 **
HRR30s (bpm)0.27 *−0.06−0.23−0.23−0.27 *−0.16−0.140.46 **0.51 **
HRR1m (bpm)0.14−0.08−0.15−0.15−0.22−0.11−0.080.42 **0.48 **
HRR2m (bpm)0.14−0.17−0.15−0.15−0.23−0.12−0.050.33 *0.43 **
* Significant correlation of p < 0.05 (2-tailed); ** significant correlation of p < 0.01 (2-tailed). Abbreviation: BMI, body mass index; WC, waist circumference; LL, leg length; Dist, total distance walked; RPE, rate of perceived exertion; VO2max, maximal oxygen consumption; RHR, resting heart rate; 3MWT, 3 min walk test; spm, steps per minute; HR1m, heart rate at 1 min; HR2m, heart rate at 2 min; HR3m, heart rate at 3 min; HRR30s, heart rate recovery at 30 s; HRR1m, heart rate recovery at 1 min; HRR2m, heart rate recovery at 2 min.
Table 4. Correlation of maximal oxygen consumption and exercise related variables.
Table 4. Correlation of maximal oxygen consumption and exercise related variables.
Correlation between 3MWT120 and VO2maxCorrelation between 3MWT130 and VO2max
Measured variables
RHR (bpm)−0.27 *−0.27 *
HR1m (bpm)−0.25−0.19
HR2m (bpm)−0.33 *−0.27 *
HR3m (bpm)−0.31 *−0.29 *
HRR30s (bpm)−0.31 *−0.31 *
HRR1m (bpm)−0.26 *−0.28 *
HRR2m (bpm)−0.14−0.27 *
Total distance walked (m)0.220.28 *
RPE−0.19−0.20
How fast HR increases with walking
HR1m-RHR−0.06−0.02
HR2m-RHR−0.18−0.14
HR3m-RHR−0.17−0.16
HR2m-HR1m−0.26 *−0.29 *
HR3m-HR2m0.03−0.13
How fast HR decrease once stop walking
HR3m-HR1m−0.21−0.31 *
HRR30s-HR3m−0.06−0.05
HRR1m-HR3m0.120.05
HRR2m-HR3m0.240.12
HRR30s-HRR1m0.230.12
HRR30s-HRR2m0.31 *0.19
HRR1m-HRR2m0.26 *0.15
Total change in HR
RHR to HR3m to HRR30s−0.10−0.08
RHR to HR3m to HRR1m−0.16−0.11
RHR to HR3m to HRR2m−0.19−0.11
How close HR return to RHR
HRR30s-RHR−0.20−0.19
HRR1m-RHR−0.13−0.17
HRR2m-RHR0.05−0.12
* Significant correlation of p < 0.05 (2-tailed). Abbreviation: 3MWT120, 3 min walk test at a cadence of 120 spm; 3MWT130, 3 min walk test at a cadence of 130 spm; spm, steps per minute; VO2max, maximal oxygen consumption; RHR, resting heart rate; HR1m, heart rate at 1 mi; HR2m, heart rate at 2 min, HR3m, heart rate at 3 min; HRR30s, heart rate recovery after 30 s of rest; HRR1m, heart rate recovery after 1 min of rest; HRR2m, heart rate recovery after 2 min of rest; RPE, rate of perceived exertion; RHR to HR3m to HRR30s, total change in heart rate from resting heart rate until 30 s after rest; RHR to HR3m to HRR1m, total change in heart rate from resting heart rate until 1 min after rest; RHR to HR3m to HRR2m, total change in heart rate from resting heart rate until 2 min after rest.
Table 5. Maximal oxygen consumption prediction equations.
Table 5. Maximal oxygen consumption prediction equations.
No Heart Rate Variablesrr2SEE
3MWT−14.62x1 − 0.30x2 − 1.65x3 + 1.89x4 − 6.34x5 + 372.840.75 **0.574.98
Measured heart rate related variables only
3MWT120−13.77x1 − 0.36x2 − 1.56x3 + 1.83x4 − 6.12x5 − 0.14x6 + 0.003x7
+ 0.04x8− + 0.05x9 − 0.04x10 − 0.13x11 + 0.08x12 + 364.21
0.79 **0.634.97
3MWT130−13.98x1 − 0.27x2 − 1.46x3 + 1.72x4 − 5.77x5 − 0.12x6 + 0.11 x13
− 0.10x14 + 0.12x15 − 0.03x16 − 0.12x17 + 0.02x18 + 343.86
0.80 **0.654.94
Calculated heart rate related variables only
3MWT120−14.92x1 − 0.35x2 − 1.46x3 + 1.62x4 − 5.39x5 − 0.12x6 − 0.33x19
−0.30x20 − 0.09x21 + 0.32x22 + 0.18x23 + 0.10x24
+ 0.11x25 + 0.62 x26 + 342.72
0.81 **0.664.87
3MWT130−13.71x1 − 0.28x2 − 1.42x3 + 1.67x4 − 5.66x5 − 0.146x6 − 0.06x27
−0.16x28 − 0.02x29 − 0.09x30 − 0.40x31 + 0.32x32
+ 0.46x33 − 0.45 x34 + 337.86
0.80 **0.645.02
Combination of measured and calculated heart rate variables
3MWT120−16.05x1 − 0.36x2 − 1.55x3 + 1.72x4 − 5.90x5 − 0.18x6 + 0.21x7
+ 0.01x8 − 0.13x9 − 0.25x11 + 0.27x12 − 0.001x35 + 0.002x36
+ 0.04x37 − 0.001x38 + 0.04x39 + 0.001x40 + 0.003x41
− 0.003x42 + 361.49
0.84 **0.704.80
3MWT130−13.13x1 − 0.34x2 − 1.43x3 + 1.75x4 − 5.82x5 + 0.11x6 + 0.01 x13
− 0.29x14 + 0.60x15 − 0.62x17 + 0.52x18 + 0.003x43 + 0.01x44
+ 0.01x45 − 0.01x46 + 0.01x47 + 0.001x48 + 0.001x49
− 0.001x50 + 339.94
0.81 **0.655.25
** Significance of p < 0.001. SEE presented as mL/kg/min. Abbreviation: SEE, standard error of the estimate; 3MWT120, 3 min walk test at a cadence of 120 spm; 3MWT130, 3 min walk test at a cadence of 130 spm; spm, steps per minute; x1, sex; x2, age; x3, height; x4, weight; x5, body mass index; x6, resting heart rate; x7, heart rate(120) at 1 min; x8, heart rate(120) at 2 min; x9, heart rate(120) at 3 min; x10, heart rate recovery(120) at 30 s; x11, heart rate recovery(120) at 1 min; x12, heart rate recovery(120) at 2 min; x13, heart rate(130) at 1 min; x14, heart rate(130) at 2 min; x15, heart rate(130) at 3 min; x16, heart rate recovery(130) at 30 s; x17, heart rate recovery(130) at 1 min; x18, heart rate recovery(130) at 2 min; x19, difference between resting heart rate and heart rate(120) at 1 min; x20, difference between heart rate(120) at 1 min and 2 min; x21, difference between heart rate(120) at 2 min and 3 min; x22, difference between heart rate(120) at 3 min and heart rate recovery(120) at 1 min; x23, difference between heart rate recovery(120) at 1 min and heart rate recovery(120) at 2 min; x24, total change in heart rate from resting heart rate until 30 s after rest (120); x25, total change in heart rate from resting heart rate until 1 min after rest (120); x26, total change in heart rate from resting heart rate until 2 min after rest (120); x27, difference between resting heart rate and heart rate(130) at 1 min; x28, difference between heart rate(130) at 1 min and 2 min; x29, difference between heart rate(130) at 2 min and 3 min; x30, difference between heart rate(130) at 3 min and heart rate recovery(130) at 1 min; x31, difference between heart rate recovery(130) at 1 min and heart rate recovery(130) at 2 min; x32, total change in heart rate from resting heart rate until 30 s after rest (130); x33, total change in heart rate from resting heart rate until 1 min after rest (130); x34, total change in heart rate from resting heart rate until 2 min after rest (130); x35, squared difference between resting heart rate and heart rate(120) at 1 min; x36, squared difference between heart rate(120) at 1 min and 2 min; x37, squared difference between heart rate(120) at 2 min and 3 min; x38, squared difference between heart rate (120) at 3 min and heart rate recovery(120) at 1 min; x39, squared difference between heart rate recovery(120) at 1 min and heart rate recovery(120) at 2 min; x40, squared total change in heart rate from resting heart rate until 30 s after rest (120); x41, squared total change in heart rate from resting heart rate until 1 min after rest (120); x42, squared total change in heart rate from resting heart rate until 2 min after rest (120); x43, squared difference between resting heart rate and heart rate(130) at 1 min; x44, squared difference between heart rate(130) at 1 min and 2 min; x45, squared difference between heart rate (130) at 2 min and 3 min; x46, squared difference between heart rate(130) at 3 min and heart rate recovery(130) at 1 min; x47, squared difference between heart rate recovery(130) at 1 min and heart rate recovery(130) at 2 min; x48, squared total change in heart rate from resting heart rate until 30 s after rest (130); x49, squared total change in heart rate from resting heart rate until 1 min after rest (130); x50, squared total change in heart rate from resting heart rate until 2 min after rest (130).
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Yang, H.I.; Cho, W.; Lee, D.H.; Suh, S.-H.; Jeon, J.Y. Development of a New Submaximal Walk Test to Predict Maximal Oxygen Consumption in Healthy Adults. Sensors 2021, 21, 5726. https://doi.org/10.3390/s21175726

AMA Style

Yang HI, Cho W, Lee DH, Suh S-H, Jeon JY. Development of a New Submaximal Walk Test to Predict Maximal Oxygen Consumption in Healthy Adults. Sensors. 2021; 21(17):5726. https://doi.org/10.3390/s21175726

Chicago/Turabian Style

Yang, Hyuk In, Wonhee Cho, Dong Hoon Lee, Sang-Hoon Suh, and Justin Y. Jeon. 2021. "Development of a New Submaximal Walk Test to Predict Maximal Oxygen Consumption in Healthy Adults" Sensors 21, no. 17: 5726. https://doi.org/10.3390/s21175726

APA Style

Yang, H. I., Cho, W., Lee, D. H., Suh, S. -H., & Jeon, J. Y. (2021). Development of a New Submaximal Walk Test to Predict Maximal Oxygen Consumption in Healthy Adults. Sensors, 21(17), 5726. https://doi.org/10.3390/s21175726

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop